Federated Hermes, Inc. Rezolute, Inc. Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
A detailed history of Federated Hermes, Inc. transactions in Rezolute, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 11,279,327 shares of RZLT stock, worth $50 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
11,279,327
Previous 11,279,327
-0.0%
Holding current value
$50 Million
Previous $53.8 Million
39.2%
% of portfolio
0.07%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Vanguard Group Inc Valley Forge, PA2.38MShares$10.5 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$9.36 Million1.66% of portfolio
-
Marshall Wace, LLP London, X01.85MShares$8.17 Million0.01% of portfolio
-
Blackstone Inc New York, NY1.74MShares$7.73 Million0.02% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.7MShares$7.53 Million0.55% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $172M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...